- Home
- Pathology Industry
- Insulin Market and Forecasts, May 2013
Industries
- Pathology (314)
- Drug and Medication (185)
- Biotechnology (60)
- Biopharmaceutical (57)
- Fruit and Vegetable (33)
-
- Pharmaceutical (32)
- Managed Care (29)
- Dairy Products and Egg (28)
- Medical Facility (23)
- Drug Discovery and Development (21)
- Functional Food (21)
- Machine Tool and Equipment (21)
- Food (19)
- Biological Therapy (18)
- Genomics (18)
- Diagnostics (17)
- Fish and Seafood (16)
- Energy & Environment (14)
- Drug Delivery Technology (12)
- Food Ingredient (12)
Top countries
Publication dates
All regions
-
- Bahrain (1)
- Bangladesh (1)
- China (59)
- Georgia (3)
- India (167)
- Indonesia (1)
- Iran (9)
- Israel (4)
- Japan (12)
- Kazakhstan (1)
- Lebanon (2)
- Malaysia (14)
- Pakistan (10)
- Philippines (3)
- Qatar (1)
- Saudi Arabia (4)
- Singapore (5)
- South Korea (16)
- Syrian Arab Republic (1)
- Taiwan (4)
- Thailand (4)
- Turkey (1)
- Uzbekistan (2)
-
- Austria (1)
- Belarus (1)
- Belgium (4)
- Denmark (4)
- Estonia (2)
- Finland (7)
- France (14)
- Germany (23)
- Greece (2)
- Ireland (32)
- Italy (8)
- Latvia (1)
- Lithuania (4)
- Luxembourg (1)
- Macedonia (2)
- Netherlands (6)
- Norway (2)
- Poland (7)
- Romania (1)
- Russian Federation (15)
- Slovenia (1)
- Spain (4)
- Sweden (7)
- Switzerland (3)
- Ukraine (2)
- United Kingdom (26)
-
- Australia (57)
- Austria (1)
- Belgium (4)
- Canada (53)
- Chile (3)
- Denmark (4)
- Estonia (2)
- Finland (7)
- France (14)
- Germany (23)
- Greece (2)
- Ireland (32)
- Israel (4)
- Italy (8)
- Japan (12)
- Luxembourg (1)
- Mexico (5)
- Netherlands (6)
- New Zealand (7)
- Norway (2)
- Poland (7)
- Slovenia (1)
- South Korea (16)
- Spain (4)
- Sweden (7)
- Switzerland (3)
- Turkey (1)
- United Kingdom (26)
- United States (452)
data types
- All
- Industry Data
- Company Data (1 168)
- Country Data (321)
Insulin Market and Forecasts, May 2013
You might be interested in: diabete, endocrine, nutritional and metabolic diseases, hormone, more »
industry reports
Insulin Sector Brief
- Industry report
- January 2012
- 19 pages
... Are: The inappropriate use of non-insulin (iv) syringes, which are marked in ml and not in insulin units; The use of abbreviations such as U Or Iu For units. When abbreviations ...
- Industries: Drug and Medication
Insulin Market in The United States
- Industry report
- December 2011
- 16 pages
... insulin response seems to be the ability to generate a rapidly increasing insulin profile. This notion is corroborated by recent experimental evidence that the early insulin response, when assessed ...
- Industries: Drug and Medication
- Countries: United States
Insulin Industry Brief
- Industry report
- January 2012
- 12 pages
... F chemicals supplies insulin for use in cell culture media from the largest insulin manufactu worldwide; novo nordisk. Fef chemicals is a novo nordisk company that specialises in the supply of ingredients ...
- Industries: Drug and Medication
Insulin Industry Brief
- Industry report
- July 2011
- 11 pages
- by Research Paper
... Cell failure in the presence of inherited b-cell abnormalities [3,4]. How- ever, as we will describe, the central nervous system (cns) regulates both pancreatic function and insulin sensitivity, and is therefore ...
- Industries: Drug and Medication
Insulin Sector Analysis in Denmark
- Industry report
- July 2011
- 64 pages
... With both zn and protamine as precipitation promoters. These formulations have a much slower absorption rate than soluble insulin and are used as base treatment with 2-3 injections per day. We must know ...
- Industries: Drug and Medication
- Countries: Denmark
Insulin Sector in The United States
- Industry report
- September 2011
- 10 pages
... On insulin action, the impact of excess cortisol on gluconeogenesis and glucose effectiveness, both of which contribute to hyper- glycemia in insulin-resistant states such as diabetes mellitus, has to our ...
- Industries: Drug and Medication
- Countries: United States
Insulin Key Market Figures
- Industry report
- May 2011
- 80 pages
- by Corporation
... With approximately 3 percentage points in the first quarter of 2011 research and development Meta-analysis confirms that degludec is associated with statistically significantly less hypoglycaemia than insulin ...
- Industries: Drug and Medication
Insulin Sector in India
- Industry report
- January 2011
- 34 pages
- by Corporation
... Of insulin and insulin analog products: recombinant human insulin, glargine, aspart, and lispro. Pfizer will have exclusive rights, with some exceptions, to commercialize these products globally ...
- Industries: Drug and Medication
- Countries: India
Insulin Key Market Figures
- Industry report
- June 2011
- 98 pages
- by Corporation
... In type 1 and type 2 diabetes All trials conducted as treat-to-target trials as per regulatory requirement Programme designed to allow for pre-defined meta-analyses of hypoglycaemia versus insulin ...
- Industries: Drug and Medication
Insulin Business in The United Kingdom and Canada
- Industry report
- April 2012
- 2 pages
... Aimilano. Diabetes expanding at a rate of one new diagnosis every five seconds, the increasing incidence of diabetes is expected to almost double insulin demand and the global market value over ...
- Industries: Drug and Medication
- Countries: United Kingdom, Canada
» Purchase Premium Reports
About 100 reports for Insulin
» Read our Company Profiles
1 Companies for InsulinAccessEd
AustraliaReportlinker.com © Copyright 2013. All rights reserved.
